The primary finding from the clinical trials for the COPD biologics is reduced annual exacerbations by 30% (BOREAS trial) and 34% (NOTUS trial). In the BOREAS trial, in addition to reduced ...

Both dupilumab and mepolizumab were originally approved for asthma but were subsequently studied in patients with COPD who continue to experience symptoms and moderate-to-severe exacerbations despite ...

This publication aims to improve treatment and care for adults with chronic obstructive pulmonary disease (COPD). It provides commissioners with strategies and recommendations for frontline care, ...

Inhaled maintenance therapy is underused among hospitalized patients with COPD in China, even in those with frequent prior hospitalizations.

Indoor and outdoor pollutants and climate extremes have shown association with COPD exacerbations separately, but these factors also can act synergistically to increase morbidity in patients with high ...

Some healthy habits can help reduce your chances of getting lung infections while living with COPD. Learn more here.

The study was led by Mehmet Kesimer of the Marsico Lung Institute/Cystic Fibrosis and Pulmonary Research Center at the ...

At 72, the legendary drummer died after battling chronic obstructive pulmonary disease (COPD). TheHealthSite.com ...

GSK’s Nucala receives European Commission approval to treat chronic obstructive pulmonary disease: London, UK Saturday, February 7, 2026, 09:00 Hrs [IST] GSK plc announced the E ...

Managing mucus from COPD involves strategies that can help loosen mucus and clear it from your airway, such as staying ...